Description
CJC-1295 with DAC 2mg
Extended-Release Growth Hormone-Releasing Hormone (GHRH)
Optimise your endocrine and cellular research with our premium CJC-1295 with DAC 2mg. CJC-1295 is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) that stimulates the pulsatile release of endogenous Growth Hormone. This specific formulation includes DAC (Drug Affinity Complex), a revolutionary addition that binds covalently to circulating albumin after administration.
The inclusion of DAC dramatically extends the peptide’s half-life from a matter of minutes to approximately 6 to 8 days. This allows researchers to study sustained, elevated baselines of Growth Hormone and Insulin-like Growth Factor 1 (IGF-1) without the need for frequent daily applications. This 2mg high-purity vial is engineered to strict laboratory standards for flawless in-vitro and in-vivo evaluation.
Product Features & Highlights
-
Extended Half-Life Technology: Integrated Drug Affinity Complex (DAC) provides a prolonged therapeutic window lasting several days.
-
Sustained GH & IGF-1 Elevation: Promotes a continuous upward shift in baseline growth hormone levels for comprehensive metabolic tracking.
-
Advanced Tissue & Lipolysis Signaling: Ideal for studying long-term muscle tissue repair, cellular rejuvenation, and deep visceral fat metabolism.
-
99%+ Ultra-Purity: Rigorously tested via HPLC analysis to guarantee structural consistency, maximum stability, and zero structural degradation.
Dosage & Usage Instructions
Important Protocol Note: Due to the long-acting nature of the Drug Affinity Complex (DAC), this peptide does not require daily application. Over-frequent dosing can lead to growth hormone receptor desensitisation.
1. Standard Research Protocol
-
Weekly Dose: 1 mg to 2 mg per week.
-
Frequency: Administered either as a single weekly application, or divided into two equal split applications per week (e.g., 1mg on Monday and 1mg on Thursday).
-
Cycle Duration: Typically evaluated in research blocks of 8 to 12 weeks, followed by a mandatory 4-week clearance period to allow pituitary receptor baselines to reset.
2. Reconstitution Directions
-
Solvent: Gently introduce 2ml of Sterile Water or Bacteriostatic Water into the vial.
-
Mixing: Do not shake the vial violently. CJC-1295 with DAC possesses a delicate peptide matrix that can cleave under mechanical stress. Slowly roll or swirl the vial between your palms until the lyophilized white cake completely dissolves into a clear, perfectly colourless liquid.
Storage, Handling & Shipping
-
Lyophilized Powder (Unopened): Highly stable during standard transit temperatures. For long-term preservation, store in a refrigerator (2-8C) for up to 12 months, or freeze at -20C for up to 2 years.
-
Reconstituted Solution (Post-Mixing): Must be stored immediately in a refrigerator (2-8C) and shielded from ambient light. For peak biochemical stability, utilize the reconstituted vial within 21 to 28 days.
Product Specifications
| Attribute | Specification |
| Purity (HPLC) | 99.0% |
| Concentration | 2mg |
| Appearance | White Lyophilized Powder |
| Molecular Formula | C_{165}H_{271}N_{47}O_{46} (Base Peptide) |
| Form | 1 Single-Dose/Multi-Dose Vial |
Disclaimer: This product is sold exclusively for research, laboratory, and in-vitro development purposes. It is not intended or approved for direct human consumption.





Reviews
There are no reviews yet.